LY2109761, a Novel Transforming Growth Factor Receptor Type I and Type II Dual Inhibitor, as a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search